Latanoprost acid (Lat-FA; PhXA-85), an F-series prostaglandin (PG) analog, is a novel and potent FP receptor agonist (EC50 = 3.6 nM for human FP receptors) with the potential for the treatment of glaucoma correlates closely with the FP receptor binding affinity of the free acid. However, Lat-FA is more irritating and less effective than the prodrug latanoprost when applied directly to the eyes of human glaucoma patients.

纯度：≥98%

CAS：41639-83-2